Literature DB >> 21881255

Short- and long-term stability of lyophilised melatonin-loaded lecithin/chitosan nanoparticles.

Anita Hafner1, Marjana Dürrigl, Ivan Pepić, Jelena Filipović-Grčić.   

Abstract

The aim of this study was to establish a freeze-drying process for melatonin-loaded lecithin/chitosan nanoparticles (NPs) to preserve their chemical and physical stability for a longer time period that what is possible in an aqueous suspension. Glucose and trehalose were investigated as potential excipients during freeze-drying of NP suspensions. Lecithin/chitosan NPs were characterised by mean diameter and zeta potential, ranging between 117.4 and 328.5 nm and 6.7 and 30.2 mV, respectively, depending on the lecithin type and chitosan content in the preparation. Melatonin loadings were up to 7.1%. For all lecithin/chitosan NPs, no notable differences in the mean particle size, size distribution, zeta potential or melatonin content were observed before or immediately after the lyophilisation process or after 7 months of storage at 4 °C. The residual moisture contents of lyophilisates with glucose and trehalose immediately after the lyophilisation process varied between 4.0-4.8% and 2.4-3.0%, respectively. All lecithin/chitosan NPs had a fully amorphous nature after the freeze-drying process, as indicated by modulated differential scanning calorimetry. NP lyophilisates with glucose had a low glass transition temperature (ca. 5 °C), confirming that lyophilisation with glucose as a cryoprotectant was not appropriate. All lyophilisates with trehalose had a glass transition temperature above the room temperature, allowing formation of the cake without a collapse of the structure, which was capable of preserving its characteristics and appearance following 7 months of storage at 4 °C.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881255     DOI: 10.1248/cpb.59.1117

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  PEGylated Lecithin-Chitosan Nanoparticle-Encapsulated Alphα-Terpineol for In Vitro Anticancer Effects.

Authors:  Bahar Zarei; Masoud Homayouni Tabrizi; Amir Rahmati
Journal:  AAPS PharmSciTech       Date:  2022-03-21       Impact factor: 3.246

2.  Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug.

Authors:  Wujun Dong; Jun Ye; Weijue Wang; Yanfang Yang; Hongliang Wang; Tong Sun; Lili Gao; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2020-08-05

Review 3.  Stability of chitosan-a challenge for pharmaceutical and biomedical applications.

Authors:  Emilia Szymańska; Katarzyna Winnicka
Journal:  Mar Drugs       Date:  2015-04-01       Impact factor: 5.118

Review 4.  Self-Assembled chitosan/phospholipid nanoparticles: from fundamentals to preparation for advanced drug delivery.

Authors:  Qingming Ma; Yang Gao; Wentao Sun; Jie Cao; Yan Liang; Shangcong Han; Xinyu Wang; Yong Sun
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 5.  Nanotechnology-based advances in the efficient delivery of melatonin.

Authors:  Mohammad Mirza-Aghazadeh-Attari; Ainaz Mihanfar; Bahman Yousefi; Maryam Majidinia
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

Review 6.  Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications.

Authors:  Luiz Gustavo de Almeida Chuffa; Fábio Rodrigues Ferreira Seiva; Adriana Alonso Novais; Vinícius Augusto Simão; Virna Margarita Martín Giménez; Walter Manucha; Debora Aparecida Pires de Campos Zuccari; Russel J Reiter
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.